Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

859 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prophylactic chemotherapy with intravesical instillation of adriamycin and oral administration of 5-fluorouracil after surgery for superficial bladder cancer. The Japanese Urological Cancer Research Group for Adriamycin.
Obata K, Ohashi Y, Akaza H, Isaka S, Kagawa S, Koiso K, Kotake T, Machida T, Matsumura Y, Niijima T, et al. Obata K, et al. Among authors: machida t. Cancer Chemother Pharmacol. 1994;35 Suppl:S88-92. doi: 10.1007/BF00686928. Cancer Chemother Pharmacol. 1994. PMID: 7994795 Clinical Trial.
The 4th study of prophylactic intravesical chemotherapy with adriamycin in the treatment of superficial bladder cancer: the experience of the Japanese Urological Cancer Research Group for Adriamycin.
Matsumura Y, Akaza H, Isaka S, Kagawa S, Koiso K, Kotake T, Machida T, Niijima T, Obata K, Ohashi Y, et al. Matsumura Y, et al. Among authors: machida t. Cancer Chemother Pharmacol. 1992;30 Suppl:S10-4. doi: 10.1007/BF00686934. Cancer Chemother Pharmacol. 1992. PMID: 1394809 Clinical Trial.
Evaluation of systemic chemotherapy with methotrexate, vinblastine, adriamycin, and cisplatin for advanced bladder cancer. The Japanese Urological Cancer Research Group for Adriamycin.
Kotake T, Akaza H, Isaka S, Kagawa S, Koiso K, Machida T, Maru A, Matsumura Y, Miyagawa I, Niijima T, et al. Kotake T, et al. Among authors: machida t. Cancer Chemother Pharmacol. 1992;30 Suppl:S85-9. doi: 10.1007/BF00686950. Cancer Chemother Pharmacol. 1992. PMID: 1394826 Clinical Trial.
[Phase I study of a recombinant gamma interferon (S-6810)].
Ogawa M, Takaku F, Maekawa T, Ota K, Ichimaru M, Izuo M, Takakura K, Ikeda S, Koiso K, Machida T, et al. Ogawa M, et al. Among authors: machida t. Gan To Kagaku Ryoho. 1987 Feb;14(2):446-52. Gan To Kagaku Ryoho. 1987. PMID: 3101608 Japanese.
Comparative analysis of short-term and long-term prophylactic intravesical chemotherapy of superficial bladder cancer. Prospective, randomized, controlled studies of the Japanese Urological Cancer Research Group.
Akaza H, Isaka S, Koiso K, Kotake T, Machida T, Maru A, Matsumura Y, Niijima T, Obata K, Ohe H, et al. Akaza H, et al. Among authors: machida t. Cancer Chemother Pharmacol. 1987;20 Suppl:S91-6. doi: 10.1007/BF00262495. Cancer Chemother Pharmacol. 1987. PMID: 3117403 Clinical Trial.
Phase III trial of the Japanese Urological Cancer Research Group for Adriamycin: cyclophosphamide, adriamycin and cisplatinum versus cyclophosphamide, adriamycin and 5-fluorouracil in patients with advanced transitional cell carcinoma of the urinary bladder.
Maru A, Akaza H, Isaka S, Koiso K, Kotake T, Machida T, Matsumura Y, Nakagami Y, Niijima T, Obata K, et al. Maru A, et al. Among authors: machida t. Cancer Chemother Pharmacol. 1987;20 Suppl:S44-8. doi: 10.1007/BF00262484. Cancer Chemother Pharmacol. 1987. PMID: 3311445 Clinical Trial.
859 results